A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease (Q36078334)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

inflammatory bowel diseases

0 references

2

object named as

Paul Rutgeerts

0 references

William Jeffery Sandborn

3

object named as

William J Sandborn

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jean-Frédéric Colombel

10

object named as

Jean-Frédéric Colombel

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

4

object named as

Bruce E Sands

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Gary R Lichtenstein

1

object named as

Gary R Lichtenstein

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Freddy J Cornillie

9

object named as

Freddy Cornillie

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Robert H Diamond

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Marion Blank

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jennifer Montello

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Linda Tang

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

22 May 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

107

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1051-1063

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Thiopurine therapy in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

How to improve the safety of biologic therapy in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Methotrexate for maintenance of remission in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Adalimumab safety in global clinical trials of patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Review article: maintenance treatment of Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

2 October 2017

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

11 July 2018

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

23 September 2018

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

23 September 2018

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

23 September 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

23 September 2018

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

23 September 2018

Infliximab, azathioprine, or combination therapy for Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390465

21 October 2018

Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613901

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2012.89

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36078334&oldid=1973929673"